Exempts any covered substance use disorder and mental health treatment services and all FDA approved medications for the treatment of substance use disorder, HIV, hepatitis C and mental health conditions, from all recipient restriction program coverage and payment restrictions.
Impact
If this bill is enacted, it will significantly impact Medicaid regulations in New York, especially regarding the access of individuals to vital treatments for substance use disorders and mental health services. By exempting these services from the restrictions imposed by the recipient restriction program, individuals will be better equipped to receive the care they require without facing hurdles such as additional authorizations or payment barriers. This legislative change aims to improve health outcomes for some of the state's most vulnerable populations.
Summary
Bill A09002 seeks to amend the social services law by adding a new provision that exempts individuals receiving medical assistance from the Medicaid recipient restriction program when it comes to certain healthcare treatments. Specifically, the bill aims to ensure that people identified under the recipient restriction program can access medically necessary services for substance use disorders, mental health conditions, and other related health needs without facing payment restrictions. This includes full coverage for all FDA-approved medications applicable to these health issues.
Contention
While the bill aims to enhance access to important health services, it may not be without its points of contention. Concerns may arise regarding the funding and resources available to support these expanded services, as well as the implications for Medicaid managed care plans in terms of compliance and operational alterations. Stakeholders may debate the balance between regulatory oversight and the need for flexible, responsive healthcare support for individuals struggling with addiction and mental health challenges.
Same As
Exempts any covered substance use disorder and mental health treatment services and all FDA approved medications for the treatment of substance use disorder, HIV, hepatitis C and mental health conditions, from all recipient restriction program coverage and payment restrictions.